Albemarle (ALB) director receives 1,286-share equity grant and dividend equivalents

Rhea-AI Filing Summary

Albemarle Corporation director Gerald A. Steiner reported stock-based compensation awards rather than open-market trades. He acquired 36 shares of common stock as an annual non-employee director stock compensation installment under the 2023 Directors Plan, scheduled to vest on July 1, 2027. He also received 1,250 additional shares that represent dividends accrued on a prior stock award granted on July 1, 2025 and vested on July 1, 2026, which the company elected to settle in shares. These transactions reflect equity compensation grants and dividend equivalents, not cash purchases or sales.

Insights

Equity Compensation Analyst

Director received routine equity compensation and dividend equivalents, not trading shares in the market.

The filing shows Gerald A. Steiner, a non-employee director of Albemarle Corporation, acquiring stock through two compensation-related entries. One is a 36-share annual director stock award under the 2023 Directors Plan, and the other is 1,250 shares issued as dividends on a prior award.

Because both transactions are coded as grants (code A) with a per-share price of $0.00, they represent non-cash equity compensation rather than open-market buying. There are no derivative exercises or sales, and no 10b5-1 trading plan references in the footnotes, so the impact is routine from a governance and dilution perspective.

Overall, these awards align with standard board compensation structures that pay part of director fees in stock. They modestly increase the director’s equity exposure to ALB but do not indicate a discretionary bullish or bearish trading view, making the event neutral for most investors.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider STEINER GERALD A

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,250	$0.00	--
Grant/Award	Common Stock	36	$0.00	--

Holdings After Transaction: Common Stock — 13,196 shares (Direct, null)

Footnotes (1)

1. Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027. Represents dividends accrued on shares underlying an award granted on July 1, 2025, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan.

Key Figures

Annual director stock award: 36 shares Dividend equivalent shares: 1,250 shares Total shares granted: 1,286 shares +1 more

4 metrics

Annual director stock award 36 shares Non-employee director stock compensation to vest July 1, 2027

Dividend equivalent shares 1,250 shares Dividends accrued on July 1, 2025 award vested July 1, 2026

Total shares granted 1,286 shares Combined director award and dividend equivalents on July 1, 2026

Grant price per share $0.00 per share Both Form 4 entries reported at no cash cost

Key Terms

2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation, non-employee director stock compensation, dividends accrued, vested in full

4 terms

2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation financial

"pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation"

non-employee director stock compensation financial

"Shares represent an annual installment of non-employee director stock compensation"

dividends accrued financial

"Represents dividends accrued on shares underlying an award granted on July 1, 2025"

vested in full financial

"award granted on July 1, 2025, that vested in full on July 1, 2026"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/06/2026 - 05:29 PM Accepted by SEC EDGAR 07/06/2026 - 05:28 PM Learn about SEC filing dates

FAQ

What did Albemarle (ALB) director Gerald A. Steiner report in this Form 4?

He reported two stock-based compensation acquisitions, not market trades. Steiner received 36 shares as an annual non-employee director stock award and 1,250 shares as dividend equivalents on a prior grant, all issued under Albemarle’s 2023 Directors Plan at no cash cost.

How many Albemarle (ALB) shares did the director acquire in total?

The director acquired a total of 1,286 shares of common stock. This includes 36 shares as an annual director stock compensation installment and 1,250 shares representing accrued dividends on an earlier equity award, both settled in stock rather than cash.

Were the Albemarle (ALB) Form 4 transactions open-market purchases or sales?

No, the transactions were equity grants, not market trades. Both entries carry transaction code A for grants or awards, with a reported price of $0.00 per share, indicating stock-based compensation and dividend equivalents instead of discretionary buying or selling in the open market.

What is the 2023 Directors Plan mentioned in Albemarle’s Form 4?

It is Albemarle’s stock compensation and deferral plan for non-employee directors. Under this 2023 Directors Plan, directors like Gerald A. Steiner receive annual stock awards and can have accrued dividends on prior awards settled in shares of Albemarle common stock.

When will the new Albemarle (ALB) director stock award vest?

The 36-share annual director stock award is scheduled to vest on July 1, 2027. According to the footnote, these shares represent an installment of non-employee director stock compensation under the 2023 Directors Plan, with a defined future vesting date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

STEINER GERALD A

(Last) (First) (Middle)

ALBEMARLE CORPORATION

4250 CONGRESS STREET, SUITE 900

(Street)

CHARLOTTE NORTH CAROLINA 28209

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A		1,250(1)	A	$0	13,196	D
Common Stock	07/01/2026		A		36(2)	A	$0	13,232	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares represent an annual installment of non-employee director stock compensation pursuant to the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors of Albemarle Corporation (the "2023 Directors Plan"). Shares to vest on July 1, 2027.

2. Represents dividends accrued on shares underlying an award granted on July 1, 2025, that vested in full on July 1, 2026, which the Issuer elected to settle in shares of common stock under the 2023 Directors Plan.

Remarks:

	/s/ Corey E. Tanner, Attorney-in-fact	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)